title: [Impact of inhaled corticosteroid prescription at discharge from the emergency room on exacerbations of asthma in Japanese hospital].
abstract: BACKGROUND
  Inhaled corticosteroid (ICS) therapy has been reported to improve relapses of asthma following emergency room (ER) discharge, but the benefits of ICS prescription at discharge from the ER are unclear.
  
  
  OBJECTIVE
  To assess background of the patients who visit ER, and determine whether the prescription of ICS at ER reduces relapses in the patients with asthma.
  
  
  METHODS
  A prospective multi-center cohort study was conducted at 32 Japanese ERs. Patients aged two to 82 years who visited ER with moderate to severe exacerbation of asthma underwent questionnaire and follow-up three and six months later. The primary observations were of the asthma-related hospitalizations, ER visits, and unscheduled visits.
  
  
  RESULTS
  Among 343 asthma patients (Children: 120, Adults: 223), 33% of children and 12% of adult patients were classified as intermittent asthma, retrospectively. The patients with intermittent had the same rates of hospitalization (29.6%) and ER visits (46.2%) as those with persistent (hospitalization rate: 24.7%, ER visits: 53.1%, ns) before enrolled. The odds ratio for hospitalization in the patients received ICS at the discharge from the ER, compared with the patients who did not received ICS, yielded 0.256 (95% confidence interval, 0.069 to 0.942; p=0.040) by multinomial logistic regression model.
  
  
  CONCLUSIONS
  Prescribing ICS at discharge from the ER to asthma patients is associated with the reduction of risk for asthma-related hospitalization. For patients discharged from the ER, including mild intermittent asthma, ICS might be prescribed.
authors.affiliation: Department of Respiratory Medicine, St Luke's International Hospital. chonaoh@luke.or.jp
authors.forename: Naohiko
authors.initials: N
authors.lastname: Chohnabayashi
authors.forename: Kumiya
authors.initials: K
authors.lastname: Sugiyama
authors.forename: Masahiko
authors.initials: M
authors.lastname: Kato
authors.forename: Teruaki
authors.initials: T
authors.lastname: Kimura
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Mochiduki
authors.forename: Hirotaka
authors.initials: H
authors.lastname: Yasuba
authors.forename: Shigemi
authors.initials: S
authors.lastname: Yoshihara
authors.forename: Takeshi
authors.initials: T
authors.lastname: Fukuda
authors.forename: Akihiro
authors.initials: A
authors.lastname: Morikawa
authors.forename: Mitsuru
authors.initials: M
authors.lastname: Adachi
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004636:Emergency Service, Hospital; D006761:Hospitals / Q000706:statistics & numerical data; D006801:Humans; D008875:Middle Aged; D010351:Patient Discharge; D055656:Prescriptions
chemical_list: D000305:Adrenal Cortex Hormones